Remedium Lifecare Limited (BOM: 539561)

Market Cap	3.52B
Revenue (ttm)	37.89B
Net Income (ttm)	291.20M
Shares Out	403.20M
EPS (ttm)	0.72
PE Ratio	12.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	572,955
Open	8.33
Previous Close	8.33
Day's Range	7.95 - 8.74
52-Week Range	7.95 - 38.25
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Remedium Lifecare

Remedium Lifecare Limited, a pharmaceutical company, engages in the trading and sale of active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, io...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1988
• Employees: 7
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539561

Financial Performance

In 2023, Remedium Lifecare's revenue was 40.42 billion, an increase of 692.75% compared to the previous year's 5.10 billion. Earnings were 327.30 million, an increase of 503.20%.